These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3279634)

  • 1. Metabolic problems in renal transplant patients. Persistent hyperparathyroidism and hypophosphatemia: effects of intravenous calcium infusion.
    Pabico RC; McKenna BA
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):438-42. PubMed ID: 3279634
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous ethanol injection therapy in post-transplant patients with secondary hyperparathyroidism.
    Douthat WG; Orozco SE; Maino P; Cardozo G; de Arteaga J; de la Fuente J; Chiurchiu CR; Massari PU
    Transpl Int; 2007 Dec; 20(12):1031-5. PubMed ID: 17883371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood parathormone levels and sensitivity of parathyroid glands to hypercalcaemia after successful renal transplantation.
    Bernheim J; Touraine JL; Labeeuw M; Pozet N; Traeger J
    Proc Eur Dial Transplant Assoc; 1976; 12():477-82. PubMed ID: 778840
    [No Abstract]   [Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease.
    Slatopolsky E; Rutherford WE; Hoffsten PE; Elkan IO; Butcher HR; Bricker NS
    Kidney Int; 1972; 1(1):38-46. PubMed ID: 5075944
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypercalcemia after renal transplantation. Long-term follow-up data.
    David DS; Sakai S; Brennan BL; Riggio RA; Cheigh J; Stenzel KH; Rubin AL; Sherwood LM
    N Engl J Med; 1973 Aug; 289(8):398-401. PubMed ID: 4578346
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors of post renal transplant hyperparathyroidism.
    Hamidian Jahromi A; Roozbeh J; Raiss-Jalali GA; Dabaghmanesh A; Jalaeian H; Bahador A; Nikeghbalian S; Salehipour M; Salahi H; Malek-Hosseini A
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):573-6. PubMed ID: 19587496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment of hyperparathyroidism in renal transplant patients].
    Bellamy J; Benoit G; Hiesse C; Charpentier B
    Prog Urol; 1994; 4(4):509-15. PubMed ID: 7920727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parathyroid and bone. Secondary hyperparathyroidism after renal transplantation].
    Negi S; Okamoto M; Shigematsu T
    Clin Calcium; 2007 Dec; 17(12):1880-7. PubMed ID: 18057664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum parathyroid hormone levels following renal transplantation: post-transplant hypercalcemia.
    Pierides AM; Thein-Than ; Cook DB
    Clin Nephrol; 1974; 2(4):136-42. PubMed ID: 4603151
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients.
    Gonzalez E; Rojas-Rivera J; Polanco N; Morales E; Morales JM; Egido J; Amado A; Praga M
    Transplantation; 2013 Apr; 95(7):e49-52. PubMed ID: 23545517
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary hyperparathyroidism in chronic renal failure. Effects of renal homotransplantation.
    Johnson JW; Hattner RS; Hampers CL; Bernstein DS; Merrill JP; Sherwood LM
    JAMA; 1971 Jan; 215(3):478-80. PubMed ID: 4923754
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary hyperparathyroidism in chronic renal failure.
    Malmaeus J
    Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of L-arginine infusion in cyclosporine-treated transplant recipients.
    Viganò E; Badalamenti S; Paone G; Como G; Finazzi S; Tarantino A; Galmarini D; Ponticelli C
    Transplant Proc; 1994 Oct; 26(5):2622-3. PubMed ID: 7940816
    [No Abstract]   [Full Text] [Related]  

  • 15. Berson and Yalow's radioimmunoassay for parathyroid hormone (PTH): a clinical progress report.
    Roof BS; Gordan GS; Goldman L; Piel CF
    Mt Sinai J Med; 1973; 40(3):433-47. PubMed ID: 4351492
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism.
    Fischer ER; Harris DC
    Clin Nephrol; 1993 Oct; 40(4):216-20. PubMed ID: 8261678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of the parathyroid gland in patients with end-stage renal disease.
    Albertucci M; Zielinski CM; Rothberg M; Sterpetti A; Klingman R; Ronk JF
    Surg Gynecol Obstet; 1988 Jul; 167(1):49-52. PubMed ID: 3381185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic approach to the hypophosphataemia of renal transplantation.
    Plaza JJ; Castrillo JM; Alvarez V; Rapado A; Hernando L
    Proc Eur Dial Transplant Assoc; 1981; 18():380-6. PubMed ID: 7036156
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of keto acids on serum parathyroid hormone levels in patients with chronic renal failure.
    Fröhling PT; Kokot F; Schmicker R; Kaschube I; Lindenau K; Vetter K
    Clin Nephrol; 1983 Oct; 20(4):212-5. PubMed ID: 6641029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.